LAUSR

Heart failure (HF) is a disease with high mortality and morbidity rate. Previous studies have shown that microRNAs (miRNAs) may be implicated in the pathogenesis of HF, potentially being able to improve the cardiac function in an HF rat model. The present study was designed to define the role of miR‐665 in the cardiac function of the HF rats. Following the establishm;ent of the rat models of HF, the functional role miR‐665 in HF was determined using an ectopic expression and knockdown experiments. The cardiac function was evaluated with the determination of ventricular mass index and hemodynamic parameters. Terminal deoxynucleotidyl transferase dUTP nick end labeling staining was performed, with the apoptosis of cardiac cells detected in the process. The expression of miR‐665, glucagon‐like peptide 1 receptor (GLP1R), cyclic adenosine monophosphate (cAMP) signaling pathway‐related, and apoptosis‐related genes was examined. Enzyme‐linked immunosorbent assay was conducted to determine the levels of inflammation‐related genes. Initially, the upregulation of miR‐665, downregulation of GLP1R, and inactivation of cAMP signaling pathway were observed in HF rats. GLP1R was a target of miR‐665. Forced expression of miR‐665 promoted cell apoptosis and inhibited GLP1R and the cAMP signaling pathway. In addition, miR‐665 overexpression has been known to impair cardiac function, promote inflammatory response while elevating malondialdehyde and superoxide dismutase levels, and decreasing mitochondrial respiratory chain enzyme activities. Furthermore, we also observed that the effects of miR‐665 inhibition had been reversed when the cAMP signaling pathway was also inhibited. This study demonstrates that miR‐665 inhibition can stabilize the cardiac function of HF rats via the cAMP signaling pathway via upregulation of the GLP1R.